Dopamine-1 receptor agonist, but not cocaine, modulates σ1 gene expression in SVG cells

Journal of Molecular Neuroscience

Volumn 29, Issue 2, 2006, Pages 169-176

  Ben Ami, Oren ^a   Kinor, Noa ^a   Perelman, Alexander ^a   Yadid, Gal ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

1 receptor; Cocaine; Dopamine; Dopamine 1 receptor; Human fetal astrocyte cell line; Real time quantitative RT PCR

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; MESSENGER RNA; SIGMA 1 OPIATE RECEPTOR;

ARTICLE; ASTROCYTE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; CELL LINE; COCAINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, DOPAMINE D1; RECEPTORS, SIGMA;

EID: 33748446083     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:29:2:169     Document Type: Article

References (40)

1. Aerts J. L., Gonzales M. I., and Topalian S. L. (2004) Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR. Biotechniques 36, 84-86, 88, 90-91.
2. Bastianetto S., Rouquier L., Perrault G., and Sanger D. J. (1995) DTG-induced circling behaviour in rats may involve the interaction between sigma sites and nigrostriatal dopaminergic pathways. Neuropharmacology 34, 281-287.
3. Booth R. G. and Baldessarini R. J. (1991) (+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Res. 557, 349-352.
4. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
5. Gilbert P. E. and Martin W. R. (1976) The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 198, 66-82.
6. Goldstein S. R., Matsumoto R. R., Thompson T. L., Patrick R. L., Bowen W. D., and Walker J. M. (1989) Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons. Synapse 4, 254-258.
7. Gonzalez-Alvear G. M. and Werling L. L. (1994) Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands. J. Pharmacol. Exp. Ther. 271, 212-219.
8. Guitart X., Codony X., and Monroy X. (2004) Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl.) 174, 301-319.
9. Hyman S. E. (1996) Addiction to cocaine and amphetamine. Neuron 16, 901-904.
10. Iyengar S., Dilworth V. M., Mick S. J., Contreras P. C., Monahan J. B., Rao T. S., and Wood P. L. (1990) Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDAreceptors. Brain Res. 524, 322-326.
11. Kahoun J. R. and Ruoho A. E. (1992) (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor. Proc. Natl. Acad. Sci. U. S. A. 89, 1393-1397.
12. Kinor N., Geffen R., Golomb E., Zinman T., and Yadid G. (2001) Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes. Glia 33, 143-150.
13. Koob G. F. (1996) Drug addiction: the yin and yang of hedonic homeostasis. Neuron 16, 893-896.
14. Kuhar M. J., Ritz M. C., and Boja J. W. (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14, 299-302.
15. Major E. O., Miller A. E., Mourrain P., Traub R. G., de Widt E., and Sever J. (1985) Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. U. S. A. 82, 1257-1261.
16. Matsumoto R. R., McCracken K. A., Friedman M. J., Pouw B., De Costa B. R., and Bowen W. D. (2001) Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice. Eur. J. Pharmacol. 419, 163-174.
17. Matsumoto R. R., McCracken K. A., Pouw B., Zhang Y., and Bowen W. D. (2002) Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides. Neuropharmacology 42, 1043-1055.
18. Maurice T., Martin-Fardon R., Romieu P., and Matsumoto R. R. (2002) Sigma(1) (σ (1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci. Biobehav. Rev. 26, 499-527.
19. McCracken K. A., Bowen W. D., De Costa B. R., and Matsumoto R. R. (1999) Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity. Eur. J. Pharmacol. 370, 225-232.
20. Minabe Y., Matsuno K., and Ashby C. R. Jr. (1999) Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study. Synapse 33, 129-140.
21. Nestler E. J. (2001) Molecular neurobiology of addiction. Am. J. Addict. 10, 201-217.
22. Nuwayhid S. J. and Werling L. L. (2003) Steroids modulate N-methyl-D-aspartate-stimulated [3H] dopamine release from rat striatum via sigma receptors. J. Pharmacol. Exp. Ther. 306, 934-940.
23. Patrick S. L., Walker J. M., Perkel J. M., Lockwood M., and Patrick R. L. (1993) Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands. Eur. J. Pharmacol. 231, 243-249.
24. Peeters M., Romieu P., Maurice T., Su T. P., Maloteaux J. M., and Hermans E. (2004) Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine. Eur. J. Neurosci. 19, 2212-2220.
25. Pfaffl M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
26. Pfaffl M. W., Horgan G. W., and Dempfle L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36.
27. Poncelet M., Santucci V., Paul R., Gueudet C., Lavastre S., Guitard J., et al. (1993) Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A. Neuropharmacology 32, 605-615.
28. Rasmussen R. (2001) "Quantification on the LightCycler" in Meuer S., Wittwer C., and Nakagawara K. (eds.). Rapid Cycle Real-Time PCR: Methods and Applications. Springer Press, Heidelberg, Germany, pp 21-43.
29. Ritz M. C. and George F. R. (1993) Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J. Pharmacol. Exp. Ther. 264, 1333-1343.
30. Rocha B. A., Fumagalli F., Gainetdinov R. R., Jones S. R., Ator R., Giros B., et al. (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1, 132-137.
31. Romieu P., Martin-Fardon R., and Maurice T. (2000) Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference. Neuroreport 11, 2885-2888.
32. Romieu P., Phan V. L., Martin-Fardon R., and Maurice T. (2002) Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology 26, 444-455.
33. Rozen S. and Skaletsky H. (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365-386.
34. Sharkey J., Glen K. A., Wolfe S., and Kuhar M. J. (1988) Cocaine binding at sigma receptors. Eur. J. Pharmacol. 149, 171-174.
35. Sora I., Wichems C., Takahashi N., Li X. F., Zeng Z., Revay R., et al. (1998) Cocaine reward models: conditioned place preference can be established in dopa. Proc. Natl. Acad. Sci. U. S. A. 95, 7699-7704.
36. Su T. P. and Hayashi T. (2001) Cocaine affects the dynamics of cytoskeletal proteins via sigma(1) receptors. Trends Pharmacol. Sci. 22, 456-458.
37. Tornatore C., Baker-Cairns B., Yadid G., Hamilton R., Meyers K., Atwood W., et al. (1996) Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line; in vitro characterization and engraftment into the rodent striatum. Cell Transplant. 5, 145-163.
38. Ujike H., Kuroda S., and Otsuki S. (1996) σ Receptor antagonists block the development of sensitization to cocaine. Eur. J. Pharmacol. 296, 123-128.
39. Weatherspoon J. K., Gonzalez-Alvear G. M., Frank A. R., and Werling L. L. (1996) Regulation of [3H] dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors. Schizophr. Res. 21, 51-62.
40. Weiser S. D., Patrick S. L., Mascarella S. W., Downing-Park J., Bai X., Carroll F. I., et al. (1995) Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of sigma receptor ligands. Eur. J. Pharmacol. 275, 1-7.